BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8936330)

  • 1. Two classes of ethidium-bromide-resistant mutants of Streptomyces lividans 66.
    Lee LF; Huang YJ; Chen CW
    Microbiology (Reading); 1996 Apr; 142 ( Pt 4)():1041-1047. PubMed ID: 8936330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. argJ mutations are highly inducible by ethidium bromide in proB strains of Streptomyces lividans: implication of pathway interactions.
    Chou CF; Chen CW
    Biochem Biophys Res Commun; 1992 Dec; 189(2):1101-9. PubMed ID: 1472020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repressed multidrug resistance genes in Streptomyces lividans.
    Lee LF; Huang YJ; Chen CW
    Arch Microbiol; 2003 Sep; 180(3):176-84. PubMed ID: 12937892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA deletions in spontaneous chloramphenicol-sensitive mutants of Streptomyces coelicolor A 3(2) and Streptomyces lividans 66.
    Flett F; Cullum J
    Mol Gen Genet; 1987 May; 207(2-3):499-502. PubMed ID: 3475527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-component multidrug efflux pump, EbrAB, in Bacillus subtilis.
    Masaoka Y; Ueno Y; Morita Y; Kuroda T; Mizushima T; Tsuchiya T
    J Bacteriol; 2000 Apr; 182(8):2307-10. PubMed ID: 10735876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton motive force-driven and ATP-dependent drug extrusion systems in multidrug-resistant Lactococcus lactis.
    Bolhuis H; Molenaar D; Poelarends G; van Veen HW; Poolman B; Driessen AJ; Konings WN
    J Bacteriol; 1994 Nov; 176(22):6957-64. PubMed ID: 7961458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA amplification and an unstable arginine gene in Streptomyces lividans 66.
    Altenbuchner J; Cullum J
    Mol Gen Genet; 1984; 195(1-2):134-8. PubMed ID: 6092842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid curing and generation of mutations induced with ethidium bromide in streptomycetes.
    Crameri R; Davies JE; Hütter R
    J Gen Microbiol; 1986 Mar; 132(3):819-24. PubMed ID: 3734751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a two-gene operon epeRA involved in multidrug resistance in Streptomyces clavuligerus.
    Rodríguez-García A; Santamarta I; Pérez-Redondo R; Martín JF; Liras P
    Res Microbiol; 2006; 157(6):559-68. PubMed ID: 16797928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of Streptomyces lividans mutants deficient in intraplasmid recombination.
    Tsai JF; Chen CW
    Mol Gen Genet; 1987 Jun; 208(1-2):211-8. PubMed ID: 3112520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of chloramphenicol production in strains of Streptomyces species 3022alpha treated with acriflavine and ethidium bromide.
    Michelson AM; Vining LC
    Can J Microbiol; 1978 Jun; 24(6):662-9. PubMed ID: 667733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of antibiotic production with ethidium bromide in Streptomyces hygroscopicus.
    Ogura M; Tanaka T; Furihata K; Shimazu A; Otake N
    J Antibiot (Tokyo); 1986 Oct; 39(10):1443-9. PubMed ID: 3781913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of an unstable argG gene to a 5.7-kilobase amplifiable DNA sequence in Streptomyces lividans 66.
    Betzler M; Dyson P; Schrempf H
    J Bacteriol; 1987 Oct; 169(10):4804-10. PubMed ID: 2820944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular cloning of tylosin-producing Streptomyces fradiae B-45 genes determining increased inducible resistance to tylosin in Streptomyces lividans TK64].
    Furs AR; Orekhov AV
    Antibiot Khimioter; 1989 May; 34(5):332-7. PubMed ID: 2742417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of a particular DNA sequence in Streptomyces ambofaciens RP181110 reversibly prevents spiramycin production.
    Dary A; Bourget N; Girard N; Simonet JM; Decaris B
    Res Microbiol; 1992 Jan; 143(1):99-112. PubMed ID: 1641517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance.
    Sander P; De Rossi E; Böddinghaus B; Cantoni R; Branzoni M; Böttger EC; Takiff H; Rodriquez R; Lopez G; Riccardi G
    FEMS Microbiol Lett; 2000 Dec; 193(1):19-23. PubMed ID: 11094273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual regulatory mechanism for a Streptomyces multidrug resistance gene, ptr, involving three homologous protein-binding sites overlapping the promoter region.
    Salah-Bey K; Thompson CJ
    Mol Microbiol; 1995 Sep; 17(6):1109-19. PubMed ID: 8594330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of novobiocin resistance genes in the novobiocin-producing organism Streptomyces niveus.
    Hoggarth JH; Ritchie DA
    J Appl Bacteriol; 1995 May; 78(5):543-7. PubMed ID: 7538993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ethidium bromide and acriflavine on streptomycin production by Streptomyces bikiniensis.
    Shaw PD; Piwowarski J
    J Antibiot (Tokyo); 1977 May; 30(5):404-8. PubMed ID: 885798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of actinorhodin production by rpsL (encoding ribosomal protein S12) mutations that confer streptomycin resistance in Streptomyces lividans and Streptomyces coelicolor A3(2).
    Shima J; Hesketh A; Okamoto S; Kawamoto S; Ochi K
    J Bacteriol; 1996 Dec; 178(24):7276-84. PubMed ID: 8955413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.